Does Anthem Cover Saxenda?
The verdict
Conditional on most plans
Anthem (Elevance Health) covers Saxenda only when the employer group has elected a weight-loss or anti-obesity-medication benefit. Saxenda (liraglutide 3.0mg) IS FDA-approved on-label for chronic weight management — this is true, and unlike the diabetes-only GLP-1s (Trulicity, Victoza) it is correct to say so. But FDA on-label status does not override plan-level AOM exclusions. Standard Medicare Part D excludes Saxenda by statute, and Saxenda is NOT in the 2026 Medicare GLP-1 Bridge. Elevance (Anthem's parent) administers Medicaid in multiple states, and state-level weight-loss coverage is volatile. Generic liraglutide (August 2025) is an emerging lower-cost option subject to the same coverage rules as brand Saxenda. Key distinction: Saxenda (weight loss) and Victoza (diabetes) are both liraglutide — Anthem covers Victoza for type 2 diabetes under most plans; Saxenda falls under the entirely separate weight-loss benefit. Anthem cells are representative composites; verify on anthem.com.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Anthem using your member ID.
Key facts
Saxenda (liraglutide 3.0mg) IS FDA-approved for chronic weight management; Victoza (liraglutide 1.2/1.8mg) is FDA-approved for type 2 diabetes. Anthem covers these under entirely separate benefit categories.
FDA prescribing information: Saxenda (NDA 206321); Victoza (NDA 022341)
Saxenda is not in the 2026 Medicare GLP-1 Bridge. The Bridge covers Wegovy formulations, Foundayo, and the Zepbound KwikPen only.
CMS Medicare GLP-1 Bridge fact sheet, 2026
An authorized generic liraglutide 3.0mg (Teva) entered the market in August 2025 as a lower-cost Saxenda equivalent.
Novo Nordisk authorized generic announcement; Drugs.com generic tracker, 2025
Medicare vs. commercial coverage
Whether Anthem covers Saxenda depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D statutorily excludes Saxenda as a weight-loss agent. This applies to all Anthem Medicare Advantage and Part D plans. Saxenda is NOT in the 2026 Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), which covers only Wegovy formulations, Foundayo, and the Zepbound KwikPen. CMS did not include Saxenda in the Bridge's covered drug list. Generic liraglutide (August 2025) faces the same statutory Medicare Part D weight-loss exclusion as brand Saxenda. Anthem Medicare members are ineligible for manufacturer savings cards under federal anti-kickback rules. NovoCare patient assistance (Novo Nordisk) may be available for eligible low-income patients.
Commercial / Employer
Group & marketplace plans
Anthem commercial and employer plans (Elevance Health's large PPO/HMO network) cover Saxenda only when the employer group has elected a weight-loss or AOM benefit. Per the 2025 KFF Employer Health Benefits Survey, only 19% of firms with 200+ workers covered GLP-1s for weight loss. Self-funded employer groups frequently carve out weight-loss drugs even within Anthem's network. Where the AOM benefit is present, prior authorization requires BMI of 30 or higher, or 27 or higher with a qualifying weight-related comorbidity; documented lifestyle/weight-management program; continuing authorization on documented weight loss. ACA marketplace plans: Anthem ACA marketplace plans frequently exclude anti-obesity medications. Anthem Medicaid (Elevance multi-state): weight-loss coverage is volatile and state-specific. Elevance administers Medicaid in multiple states (Virginia, Georgia, Missouri, Indiana, Kansas, etc.) and each state's PDL for weight-loss drugs varies. Some states have cut adult GLP-1 weight-loss coverage (California, Pennsylvania); others maintain it with PA. Confirm current PDL status for your Elevance state Medicaid plan. Saxenda vs. Victoza: Anthem covers Victoza for type 2 diabetes across most commercial plans with PA; Saxenda falls under the weight-loss benefit category and is entirely separate. Do not assume Victoza coverage implies Saxenda coverage. Novo Nordisk savings programs available for commercially insured Anthem members whose plan covers Saxenda; NOT available to Medicare or Medicaid members. All cells are representative composites; verify on anthem.com.
The 4 boxes you must tick to get approved
Commercial plans that will consider Saxenda require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Saxenda actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Saxenda brand cash price is high as an injectable GLP-1 pen (specific list price not publicly standardized for Saxenda; Novo Nordisk GLP-1 pens are in the several-hundred-dollar range per month). Generic liraglutide 3.0mg (Teva, August 2025) is an emerging lower-cost alternative — ask your pharmacist for current generic pricing. NovoCare patient assistance may help eligible low-income patients.
List price with no coverage — before any manufacturer savings card.
With coverage
Where Saxenda is covered on an Anthem commercial plan with an AOM benefit, co-pays vary by formulary tier. Novo Nordisk savings programs are available for commercially insured Anthem members whose plan covers Saxenda; NOT available to Medicare or Medicaid members under federal anti-kickback rules.
Typical monthly copay once prior authorization is approved.
Saxenda is not in the 2026 Medicare GLP-1 Bridge. Generic liraglutide (August 2025) faces the same Medicare Part D weight-loss exclusion as brand Saxenda. Manufacturer savings programs exclude Medicare and Medicaid. All figures are estimates; verify with Anthem and your pharmacy.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search Anthem's drug-search to confirm AOM benefit status and Saxenda coverage
Log into anthem.com with your Anthem member ID and search for Saxenda or liraglutide 3.0mg in the drug-search tool. If no AOM coverage appears, your plan likely has a weight-loss drug carve-out — confirm with HR or Anthem member services (1-800-676-2583 for commercial). Do not search for Victoza as a proxy: Victoza's diabetes coverage does not indicate Saxenda's weight-loss coverage. Elevance Medicaid members: contact your state Medicaid plan directly for the current PDL status of Saxenda in your state.
- 2
Confirm with your prescriber that Saxenda is the correct product (not Victoza)
Saxenda and Victoza are both liraglutide but are different FDA-approved products for different indications. If you want weight-loss liraglutide, your prescriber must prescribe Saxenda (3.0mg) or generic liraglutide 3.0mg for weight management — not Victoza. Anthem covers these under separate benefit categories; a prescription for the wrong product will be denied under the incorrect coverage pathway.
- 3
Ask about generic liraglutide and NovoCare if Anthem excludes Saxenda
Generic liraglutide 3.0mg (Teva authorized generic, August 2025) is an emerging lower-cost option. Current cash pricing is developing; ask your pharmacist for the latest figure. NovoCare (Novo Nordisk's patient assistance program) may assist eligible low-income patients whose Anthem plan excludes Saxenda. Commercial Anthem members whose plan does cover Saxenda can use Novo Nordisk savings programs; Medicare and Medicaid members cannot.
Options if Anthem won't cover Saxenda
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic liraglutide 3.0mg (Teva, August 2025)
An authorized generic for Saxenda launched in August 2025. It is subject to the same Anthem PA requirements and the same Medicare Part D weight-loss exclusion as brand Saxenda, but may be lower-cost at cash. Ask your pharmacist for current pricing.
NovoCare patient assistance program (Novo Nordisk)
For Anthem members whose plan excludes Saxenda or who are uninsured, NovoCare may provide assistance based on income eligibility. Contact NovoCare at novonordisk-us.com/patients/patient-assistance-program.html.
Wegovy (semaglutide 2.4mg) — if Anthem has an AOM benefit
If your Anthem employer plan has a weight-loss drug benefit, Wegovy (semaglutide 2.4mg) may be an alternative injectable weight-loss GLP-1 with its own coverage and PA requirements. Wegovy and Saxenda are different molecules; verify Wegovy's tier and PA criteria on anthem.com separately.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Anthem covers Saxenda only if your employer plan includes a weight-loss or anti-obesity-medication benefit. Saxenda IS FDA-approved for chronic weight management — but FDA approval does not override plan-level AOM exclusions. Standard Medicare Part D excludes it, and Saxenda is not in the 2026 Medicare GLP-1 Bridge. Elevance multi-state Medicaid coverage is volatile and state-dependent. Generic liraglutide (August 2025) is an emerging lower-cost option subject to the same coverage rules. Verify on anthem.com.
No — they are the same molecule but entirely different products with different coverage. Victoza (liraglutide 1.2mg/1.8mg) is FDA-approved for type 2 diabetes and cardiovascular risk reduction; Anthem covers it for diabetes across most commercial plans with PA. Saxenda (liraglutide 3.0mg) is FDA-approved for chronic weight management; Anthem covers it only under a weight-loss drug benefit, which many plans lack. Do not assume Victoza coverage implies Saxenda coverage — they are separate benefit categories at Anthem.
No. Medicare Part D excludes Saxenda as a weight-loss agent by statute, and Saxenda was not included in the 2026 Medicare GLP-1 Bridge. This applies to all Anthem Medicare Advantage plans. Generic liraglutide faces the same exclusion. Anthem Medicare members are ineligible for manufacturer savings cards. NovoCare patient assistance may help eligible low-income Medicare beneficiaries access Saxenda at reduced cost.
Elevance Health administers Medicaid in multiple states, and weight-loss drug coverage varies significantly by state. Some states that Elevance serves have cut adult weight-loss GLP-1 coverage (California, Pennsylvania); others maintain coverage with prior authorization. There is no single Elevance Medicaid answer for Saxenda. Contact your specific Elevance state Medicaid plan (Anthem HealthKeepers, Amerigroup, Simply Healthcare, WellPoint, etc.) or check your state's preferred drug list for Saxenda's current status in your state.
The 2026 Medicare GLP-1 Bridge was designed around semaglutide (Wegovy/Foundayo) and tirzepatide (Zepbound KwikPen). Saxenda is an injectable weight-loss GLP-1 like Wegovy, but CMS chose not to include it in the Bridge's covered drug list. This means Anthem Medicare Advantage members cannot access Saxenda through the Bridge — it is a CMS policy decision, not an Anthem decision. This is a key distinction for Anthem Medicare members comparing their weight-loss GLP-1 options.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreDoes Blue Cross Blue Shield Cover Saxenda? 2026 | Curex
BCBS covers Saxenda only with an AOM benefit — on-label approval doesn't guarantee coverage. Medicare excludes it; generic liraglutide arrived 2025.
Read moreWhether or not Anthem covers Saxenda, a weight-management path without insurance is available
Saxenda is FDA-approved for weight loss but excluded on Anthem Medicare plans and many employer plans with AOM carve-outs. Curex offers compounded semaglutide from $49/month and compounded tirzepatide from $149/month at getcurex.com/cl/glp — no insurance required, no prior authorization. Compounded semaglutide and tirzepatide are not the same medication as Saxenda. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Saxenda and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Anthem before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Saxenda and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.